Fewer Disease Flares With GLP-1 Therapy In a retrospective study led by Shreya Sakthivel, Chief Resident of Internal Medicine at Anne Arundel Medical Center, investigators found that RA patients receiving disease-modifying antirheumatic drugs (DMARDs) who also took GLP-1 receptor agonists or SGLT2 inhibitors experienced fewer disease flares than those on DMARDs alone
Not just on paper, but in practice
65% of new US GLP-1 prescriptions in the quarter were for Wegovy
The collagen data has direct relevance for follicle health
A growing number of people are exploring GLP-1 medications for weight loss or as part of a broader effort to improve metabolic health, stabilize energy, and prevent long-term issues like diabetes or cardiovascular disease
To remediate such water bodies or treatment systems while effectively capturing and isolating MPs from their environment, practitioners strategically locate screens and grids to minimize the effects of pervasive pollutants